观点联合利华

The basic problem with Unilever’s £50bn healthcare bid
联合利华开展大手笔收购的根本问题在哪里?

Whether or not it buys GSK’s consumer health unit, the company is on the hunt for a big acquisition
联合利华500亿英镑收购葛兰素史克消费品部门的尝试,令人担忧债务水平高企和此举究竟能够节省多少成本。然而,这里有一个更为基本的问题。

Unilever, as we know from Terry Smith, is keen on purpose. And the purpose of its sudden announcement of a strategic rethink and organisational overhaul was very clear: damage limitation.

联合利华(Unilever),就像特里•史密斯(Terry Smith,英国知名基金经理——译者注)告诉我们的,很有目的感。其突然宣布战略反思和组织改革的目的非常明确: